Cita APA

Timmerman, J., Herbaux, C., Ribrag, V., Zelenetz, A. D., Houot, R., Neelapu, S. S., & Carpio Segura, C. C. (2020). Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.

Citación estilo Chicago

Timmerman, John, Charles Herbaux, Vincent Ribrag, Andrew D. Zelenetz, Roch Houot, Sattva S. Neelapu, y Cecilia Carmen Carpio Segura. Urelumab Alone or in Combination With Rituximab in Patients With Relapsed or Refractory B-cell Lymphoma. 2020.

Cita MLA

Timmerman, John, et al. Urelumab Alone or in Combination With Rituximab in Patients With Relapsed or Refractory B-cell Lymphoma. 2020.